Cientifica Ltd., Jan 2012, Pages: 121
of government funding to a total of $67.5 billion from 2000 to 2011.
Nanotechnology in DrugDelivery: Global Markets, indicates nanotech-enabled drugdelivery therapeutics is set to grow from a current value
Markets and Markets, Feb 2011, Pages: 253
their market position.
This report highlights the global injectable drugdelivery market segmented as below:
- Injectable systems (Sustained Release Injectable Systems, Needleless Systems Microneedle Injectors
Bizacumen Inc., Nov 2009, Pages: 165
in powder formulations, and innovations in particle engineering.
These and other market data and trends are presented in "Pulmonary DrugDelivery Technologies: A Global Market Perspective" by BizAcumen, Inc
Arrowhead Publishers, May 2006, Pages: 233
mechanisms. Thus, post patent expiry sales can be switched from the ethical manufacturer to the drugdelivery sector.
The GlobalDrugDelivery Market: Research Trends and Market Outlook is an up-to-date guide
Global Industry Analysts, Inc., Jan 2011, Pages: 378
Nose AS (Norway)
Pfizer, Inc. (USA)
Rexam Plc (UK) II
Schering-Plough Corporation (USA)
Sanofi-Aventis S.A. (France)
Unigene Laboratories, Inc. (USA) Intranasal DrugDelivery - Global Strategic Business
Global Industry Analysts, Inc., April 2010, Pages: 599
watermarks.
For information on site licence pricing please click on Enquire before buying PULMONARY DRUGDELIVERY TECHNOLOGIES
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
I. INTRODUCTION
Espicom Business Intelligence Ltd, Jan 2011, Pages: 634
this market. In 630+ information-packed pages, this new report DrugDelivery: Surveying the global competitive landscape (published December 2010) evaluates companies large and small from multinationals to specialist
Global Markets Direct, Dec 2008, Pages: 242
GlobalDrugDelivery Devices Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for key information and data relating to the Globaldrugdelivery
Global Markets Direct, March 2009, Pages: 237
This Medical Device report is an essential source for key information and data relating to the globalDrugDelivery Devices market. The report provides overview of key trends, regulatory information
Jain PharmaBiotech, Feb 2012, Pages: 281
. Markets for Transdermal DrugDelivery
Introduction
Global markets for drugdelivery
Geographical distribution of transdermal drugdelivery markets
Emerging transdermal drugdelivery markets in Asia
Jain PharmaBiotech, Feb 2012, Pages: 639
Introduction
Global markets for drugdelivery
Estimation of cancer drugdelivery markets
Methods used for market estimation
Cancer epidemiology
Cost of patient care in cancer
Market forecasts 2011
Arrowhead Publishers, Sep 2008, Pages: 283
to both biotech and traditional pharmacological compounds.
Key Features of This Report
- A thorough overview of both marketed and emerging drugdelivery technologies set to impact the global
Jain PharmaBiotech, Feb 2012, Pages: 772
is anticipated. Nanotechnology will be applied at all stages of drug development - from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based
GBI Research, Dec 2010, Pages: 77
1.1 List of Tables
Table 1: Elan Pharmaceutical, Drugs Based on NanoCrystal Technology, 2010
Table 2: Nanotechnology in DrugDelivery, Global, Regulatory Filing Clinical Pipeline, 2010
Table 3
GBI Research, Sep 2011, Pages: 120
Inhalers and Infusion Pumps to be Key Revenue Generators” provides key data, information and analysis on the globaldrugdelivery device market. The report provides the market landscape, competitive
Business Insights, Oct 2011, Pages: 92
drivers of uptake for specific drugdelivery routes including, oral, transdermal, pulmonary, and injectable.
- Using case studies understand how to take a strategic approach to drugdelivery based product
Arrowhead Publishers, Oct 2006
efficient drugdelivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances.
The global market for drug
Cientifica Ltd., Nov 2011, Pages: 212
forces that will fuel the growth of the nanotech drugdelivery market. The third factor at play is a combination of improved global health and a correspondingly dramatic increase in the size of the global
GBI Research, Nov 2010, Pages: 85
Market. The report also provides in-depth analysis of unmet needs, drivers and barriers that impact the global Oral DrugDelivery Market.
Further, the report provides competitive benchmarking for the leading
Markets and Markets, Feb 2011, Pages: 264
Technologies Market To Grow Exponentially
The increasing demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drugdelivery technologies market. Patent
